Brief: Eli Lilly Completes Acquisition Of POINT Biopharma
Dec 27 (Reuters) - Eli Lilly and Co LLY.N :
* LILLY COMPLETES ACQUISITION OF POINT BIOPHARMA
Source text for Eikon: ID:nPn4pddBYa
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower